Canada Proposes Amendments to Adverse Drug Reaction Reporting

October 2009

Teresa A. Reguly

Tags:

Advertising and Marketing Food and Drug Regulatory Intellectual Property Life Sciences Pharmaceuticals

Related Expertise

Related Insights

Software as Medical Devices and Digital Health in Canada: What's Next?
New IRS Approach to U.S. Tax-Deferred Spin-Offs a Boon to Pharma and Tech
Le gouvernement du Québec limite l'utilisation des programmes de fidélisation et de soutien aux patients dans un nouveau projet de règlement
Québec Government Limits use of Loyalty Cards and Patient Support in Draft Regulation
Phased Approach Announced for Proposed Changes to Self-Care Product Regulation

Back